Dissemination of Multidrug-Resistant Shigella flexneri and Shigella sonnei with Class 1, Class 2, and Atypical Class 1 Integrons in China

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Haiquan KangBing Gu

Abstract

Background: Emergence of multidrug-resistant Shigella, a major causative agent of bacterial dysentery, has generated many concerns not only in China but also worldwide. However, the prevalence of Shigella resistance caused by integron in the nonpopular season of diarrhea is not clear. Materials and Methods: Thirty-one Shigella flexneri and 22 Shigella sonnei samples collected in December 2010 from 10 cities of China were characterized for antimicrobial susceptibility, gene cassettes, widespread of integrons, and pulsed-field gel electrophoresis (PFGE) profile. Results: Multidrug resistance (MDR) was detected in 29 (93.5%) S. flexneri and 20 (90.9%) S. sonnei isolates. Class 1 integrons were detected in 25 (80.6%) S. flexneri and in 13 (59.1%) S. sonnei isolates; class 2 integrons were detected in 26 (83.9%) S. flexneri and in 19 (86.4%) S. sonnei isolates. Interestingly, the atypical class 1 integrons were mostly detected in S. flexneri (45.2%) isolates, whereas in only 1 (4.5%) S. sonnei isolate. DNA sequencing revealed two novel cassette arrays, dfrA5 and aacA4-cmlA, of class 1 integrons in S. flexneri, and dfrA17-aadA5 in S. sonnei isolates. The cassette arrays, dfrA1-sat1-aadA1 of class 2 integron and blaoxa-30-aadA1 o...Continue Reading

References

Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·P M Bennett
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·P A WhiteW D Rawlinson
Apr 16, 2002·Molecular Microbiology·Dean A Rowe-MagnusDidier Mazel
Feb 1, 2005·The Journal of Antimicrobial Chemotherapy·Gisele PeiranoDalia dos Prazeres Rodrigues
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Jacob SchlesingerYehuda Carmeli
Nov 26, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M M NaviaJ Vila
Feb 4, 2006·International Journal of Antimicrobial Agents·A Gassama-SowA Aïdara-Kane
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·A RobicsekD C Hooper
Aug 1, 2006·Bulletin of the World Health Organization·Xuan-yi WangJohn D Clemens
Nov 17, 2006·Journal of Medical Microbiology·Ashraf M AhmedTadashi Shimamoto
Jul 12, 2007·The Journal of Antimicrobial Chemotherapy·Amitabha BhattacharjeeGopal Nath
Oct 24, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S K Niyogi
Sep 10, 2008·International Journal of Antimicrobial Agents·Bing GuMingqing Tong
Mar 20, 2009·The Journal of Antimicrobial Chemotherapy·Xiao-Ying PuYang-Ming Gu
May 5, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Melissa R WongSharon Balter
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Jason P FolsterJean M Whichard
Jan 1, 2009·Microbial Biotechnology·Anna FàbregaJordi Vila
Aug 24, 2011·The Journal of Antimicrobial Chemotherapy·Wenli ZhangShenghui Cui
Feb 15, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S QiuH Song
Mar 14, 2012·The Journal of Antimicrobial Chemotherapy·Neelam TanejaMeera Sharma
Oct 24, 2014·Emerging Infectious Diseases·Juan José González-LópezM Nieves Larrosa
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S QiuH Song
Dec 2, 2015·Journal of Infection in Developing Countries·Dhiviya Prabaa Muthuirulandi SethuvelKamini Walia
Feb 2, 2016·International Journal of Environmental Research and Public Health·Han ZhangPeng Gong
Sep 14, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T QinB Gu

❮ Previous
Next ❯

Citations

Sep 6, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Christine J D GuglielminoAmy V Jennison

❮ Previous
Next ❯

Datasets Mentioned

BETA
JN651401

Methods Mentioned

BETA
electrophoresis
PCR

Software Mentioned

BioNumerics Fingerprinting

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.